Long-Term Follow-up Study to Evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients With Rotator Cuff Disease

Recruiting now

Conditions studied: Rotator Cuff Disease

In brief

The purpose of this study is to evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients with Rotator Cuff Disease

Key facts

Study ID: NCT07374679
Run by: Seoul National University Hospital
People needed: 21
Starts: 2026-01-27
Expected to finish: 2032-01-30
Last updated by the study team: 2026-05-22

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Subjects who received the investigational medicinal product in the Phase 1/2a clinical trial (ASB-IP-001).
Subjects who voluntarily agreed to participate in this long-term follow-up study and provided written informed consent.

You may not qualify if…

Subjects who cannot be contacted by any means, including telephone, mail, or e-mail, and for whom follow-up assessment is therefore not feasible.
Subjects deemed inappropriate for participation in this long-term follow-up study at the investigator's discretion, including:
Cases in which participation in the study may pose a significant risk to the subject's health or safety; ② Cases in which long-term follow-up visits or assessments are practically impossible due to cognitive impairment, communication difficulties, or similar conditions; ③ Cases in which continued participation in follow-up is unlikely due to difficulty adhering to the study schedule (e.g., prolonged hospitalization, long-term residence abroad).

Where it is running

Joint & Spine Center, SMG-SNU Boramae Medical Center, Department of Orthopedic Surgery, Seoul National University College of Medicine — Seoul, Korea, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.